|
Strategies associated with enhanced inclusion of racial and ethnic minorities in clinical cancer research: US Centers of Excellence current practices. |
|
|
|
Stock and Other Ownership Interests - Merck |
|
|
Employment - Genentech/Roche |
Stock and Other Ownership Interests - Novartis; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Merck |
|
|
|
No Relationships to Disclose |
|
|
Honoraria - Celgene; Merck |
Consulting or Advisory Role - Celgene; Merck |
|
|
Patents, Royalties, Other Intellectual Property - Elsevier Press |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Roche |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Celgene |
|
|
No Relationships to Disclose |
|
|
Employment - Susan G. Komen for the Cure |
Travel, Accommodations, Expenses - Susan G. Komen for the Cure |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Merck |
|
|
Consulting or Advisory Role - INOVA Health System |
Travel, Accommodations, Expenses - Lilly |
|
|
|
Stock and Other Ownership Interests - Lilly |
Travel, Accommodations, Expenses - Lilly |